Publication

Capecitabine and streptozocin +/- cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial.

Meyer, T
; 
Qian, W
; 
Valle, Juan W
; 
Talbot, D
; 
Cunningham, D
; 
Reed, N
; 
Meyer, T
; 
Wall, L
; 
Waters, J
; 
Ross, P
... show 8 more
Citations
Altmetric:
Abstract
Authors
Meyer, T
Qian, W
Valle, Juan W
Talbot, D
Cunningham, D
Reed, N
Meyer, T
Wall, L
Waters, J
Ross, P
Anthoney, A
Sumpter, K
Sarwar, N
Crosby, T
Begum, N
Young, G
Hardy, R
Corrie, P
Affiliation
Department of Oncology, Royal Free London NHS Foundation Trust, London,
Description
Date
2016
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Capecitabine and streptozocin +/- cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial. 2016, 27(suppl_6): 446P Ann Oncol
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620334
Embedded videos